Company Search:
Advanced Search
Sponsored Links
Raptor Pharmaceutical Corp. Company Snapshot
Raptor Pharmaceutical Corp. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Raptor Pharmaceutical Corp. with three other companies in this sector in the United States: MacroGenics Inc (2015 sales of $100.85 million of which 100% was Biopharmaceuticals), Vivus, Inc. ($95.43 million of which 100% was Therapeutic Systems), and Merrimack Pharmaceuticals Inc ($89.26 million of which 100% was Pharmaceutical Preparations).

Sales Analysis.
  Stock Performance Chart for Raptor Pharmaceutical Corp.
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 9.00
(Figures in U.S. Dollars)
1 Week 0.2%   13 Weeks 0.0%  
4 Weeks 48.5%   52 Weeks 60.4%  
Raptor Pharmaceutical Corp. Key Data:
  Ticker: RPTP Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 94,240,000
(Year Ending Jan 2016).
Employees: 158
  Currency: U.S. Dollars Market Cap: N/A
  Fiscal Yr Ends: December Shares Outstanding: N/A
  Share Type: Common Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.